(Q44741830)
Statements
The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab (English)
Cornelis G ter Meulen
Cor W M Jacobs
Jack F M Wetzels
Ina S Klasen
Andries J Hoitsma